A
Anne Jouinot
Researcher at University of Paris
Publications - 82
Citations - 1588
Anne Jouinot is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 53 publications receiving 1036 citations. Previous affiliations of Anne Jouinot include Paris Descartes University & Institut Gustave Roussy.
Papers
More filters
Journal ArticleDOI
Integrated genomic characterization of adrenocortical carcinoma
Guillaume Assié,Eric Letouzé,Martin Fassnacht,Anne Jouinot,W. Luscap,Olivia Barreau,H. Omeiri,S. Rodriguez,Karine Perlemoine,Fernande René-Corail,Nabila Elarouci,Silviu Sbiera,Matthias Kroiss,Bruno Allolio,Jens Waldmann,Marcus Quinkler,Massimo Mannelli,Franco Mantero,Thomas G. Papathomas,Ronald R. de Krijger,Antoine Tabarin,Véronique Kerlan,Eric Baudin,Frédérique Tissier,Bertrand Dousset,Lionel Groussin,Laurence Amar,Eric Clauser,Xavier Bertagna,Bruno Ragazzon,Felix Beuschlein,Rossella Libé,Aurélien de Reyniès,Jérôme Bertherat +33 more
TL;DR: Aggressive and indolent ACCs correspond to two distinct molecular entities driven by different oncogenic alterations, which are validated in an independent cohort of 77 ACCs.
Journal ArticleDOI
Pangenomic Classification of Pituitary Neuroendocrine Tumors.
Mario Neou,Mario Neou,Mario Neou,Chiara Villa,Roberta Armignacco,Roberta Armignacco,Roberta Armignacco,Anne Jouinot,Anne Jouinot,Anne Jouinot,Marie-Laure Raffin-Sanson,Amandine Septier,Amandine Septier,Amandine Septier,Franck Letourneur,Ségolène Diry,Ségolène Diry,Ségolène Diry,Marc Diedisheim,Brigitte Izac,Cassandra Gaspar,Karine Perlemoine,Karine Perlemoine,Karine Perlemoine,Victoria Verjus,Victoria Verjus,Victoria Verjus,Michèle Bernier,Anne Boulin,Jean-François Emile,Xavier Bertagna,Florence Jaffrezic,Denis Laloë,Bertrand Baussart,Jérôme Bertherat,Stephan Gaillard,Guillaume Assié +36 more
TL;DR: A comprehensive pangenomic classification of PitNETs is reported, which improves the understanding and affects the clinical stratification of patients with Pit NETs.
Journal ArticleDOI
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
Marc Hilmi,Anne Jouinot,Robert Burns,Frederic Pigneur,Rémi Mounier,Julien Gondin,Cindy Neuzillet,François Goldwasser +7 more
TL;DR: A comprehensive review providing a panoramic approach of the clinical, pharmacological and therapeutic implications of sarcopenia and body composition in oncology is proposed.
Journal ArticleDOI
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy.
Clara Vazeille,Anne Jouinot,Jean-Philippe Durand,Nathalie Neveux,Pascaline Boudou-Rouquette,Olivier Huillard,Jérôme Alexandre,Luc Cynober,François Goldwasser +8 more
TL;DR: Hypermetabolicism is correlated with clinical and biological markers of cancer cachexia and is associated with a shorter survival in metastatic cancer patients and the development of therapeutic strategies that aim to blunt hypermetabolism appears warranted.
Journal ArticleDOI
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Manuela Tiako Meyo,Anne Jouinot,Anne Jouinot,Etienne Giroux-Leprieur,Elizabeth Fabre,Marie Wislez,Marco Alifano,Karen Leroy,Pascaline Boudou-Rouquette,Camille Tlemsani,Nihel Khoudour,Jennifer Arrondeau,Audrey Thomas-Schoemann,Hélène Blons,Audrey Mansuet-Lupo,Diane Damotte,Michel Vidal,F. Goldwasser,F. Goldwasser,Jérôme Alexandre,Jérôme Alexandre,Benoit Blanchet +21 more
TL;DR: A composite biomarker using sPD-1and sPDL-1 to predict nivolumab efficacy in NSCLC patients is proposed and a larger validation study is warranted.